Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase

scientific article published on 01 January 2000

Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID10642273

P2093author name stringA Bouloumié
A Mülsch
S Klöss
P433issue1 Pt 1
P921main subjecthypertensionQ95566669
P304page(s)43-47
P577publication date2000-01-01
P1433published inHypertensionQ5958695
P1476titleAging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase
P478volume35

Reverse relations

cites work (P2860)
Q37474821Abnormal nitric oxide production in aged rat mesenteric arteries is mediated by NAD(P)H oxidase-derived peroxide.
Q34297430Age-related differences in postsynaptic increases in sweating and skin blood flow postexercise
Q43159940Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells
Q36678534Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity
Q26745608Altered Nitric Oxide System in Cardiovascular and Renal Diseases
Q34627792Alternative splicing impairs soluble guanylyl cyclase function in aortic aneurysm
Q28541815Anti-peroxynitrite treatment ameliorated vasorelaxation of resistance arteries in aging rats: involvement with NO-sGC-cGKs pathway
Q38542436Arterial structure and function in vascular ageing: are you as old as your arteries?
Q36161217CCAAT-binding factor regulates expression of the beta1 subunit of soluble guanylyl cyclase gene in the BE2 human neuroblastoma cell line
Q40088433Characterization of the human alpha1 beta1 soluble guanylyl cyclase promoter: key role for NF-kappaB(p50) and CCAAT-binding factors in regulating expression of the nitric oxide receptor
Q48358527Chronic limb-threatening ischemia could benefit from growth hormone therapy for wound healing and limb salvage.
Q37420916Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
Q38750251Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness
Q35042816Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in ageing
Q36938470Effect of oral organic nitrates on expression and activity of vascular soluble guanylyl cyclase
Q36975955Effects of estrogen on cerebrovascular function: age-dependent shifts from beneficial to detrimental in small cerebral arteries of the rat
Q41583968Elevated pressure selectively blunts flow-evoked vasodilatation in rat mesenteric small arteries.
Q28383144Estrogen, aging and the cardiovascular system
Q33683635Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathway
Q33818129Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5p
Q43264538Influence of hypertension on nitric oxide synthase expression and vascular effects of lipopolysaccharide in rat mesenteric arteries
Q90114537Lipofundin MCT/LCT Inhibits Levcromakalim-Induced Vasodilation by Inhibiting Endothelial Nitric Oxide Release
Q26799985Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction
Q24656131NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential
Q37142767Nitroxyl donors retain their depressor effects in hypertension.
Q50896297Physiological levels of thrombospondin-1 decrease NO-dependent vasodilation in coronary microvessels from aged rats.
Q27001569RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase
Q37337510Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR.
Q36052610Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species
Q49993782Role of Thioredoxin in Age-Related Hypertension.
Q37072758Role of aging versus the loss of estrogens in the reduction in vascular function in female rats
Q30575578Role of phosphodiesterase-5 inhibitors in heart failure: emerging data and concepts.
Q35009484Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels
Q38772751The Role of Reactive Oxygen and Nitrogen Species in the Expression and Splicing of Nitric Oxide Receptor
Q90400188The Role of Sirtuin1 in Regulating Endothelial Function, Arterial Remodeling and Vascular Aging
Q34042836The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies
Q36348267The impact of age on vascular smooth muscle function in humans
Q38648723Thrombospondin-1, free radicals, and the coronary microcirculation: the aging conundrum
Q38107797Vasodilator compounds derived from plants and their mechanisms of action.

Search more.